Details for New Drug Application (NDA): 209132
✉ Email this page to a colleague
The generic ingredient in CISATRACURIUM BESYLATE is cisatracurium besylate. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
Summary for 209132
Tradename: | CISATRACURIUM BESYLATE |
Applicant: | Somerset |
Ingredient: | cisatracurium besylate |
Patents: | 0 |
Pharmacology for NDA: 209132
Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Suppliers and Packaging for NDA: 209132
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 209132 | ANDA | Somerset Therapeutics, LLC | 70069-161 | 70069-161-01 | 1 VIAL in 1 CARTON (70069-161-01) / 10 mL in 1 VIAL |
CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 209132 | ANDA | Somerset Therapeutics, LLC | 70069-161 | 70069-161-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (70069-161-10) / 10 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Apr 24, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription